Pharmaceutical Executive October 22, 2021
Jonathan Sharp

Having proved its efficacy against COVID-19, mRNA technology is positioned to combat another insidious human adversary: cancer.

Cancer is generated by mutations in certain genes, which affect how our cells function. Certain genetic changes arise spontaneously during DNA replication following cell division. Others, on the other hand, are the consequence of DNA damage caused by environmental and occupational factors. Chemicals in cigarette smoke, occupational exposure to asbestos, diesel exhaust, radon, vinyl chloride, benzene, or other carcinogens are examples of these factors.

Because cancer develops from our own cells, the immune system has a far harder time distinguishing proteins in cancer cells as foreign, compared to proteins in pathogens such as viruses. However, significant breakthroughs in cancer biology and genetic sequencing...

Today's Sponsors

Qure4u
HLTH
ZeOmega

Today's Sponsors

Premier
TripleTree

Today's Sponsor

Transcarent

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech, Public Health / COVID
COVID-19 accelerated health care innovation and it isn’t slowing down
How a pandemic shines a brighter light on the need for SDoH innovation
Innovation and collaboration – the MHRA’s pandemic approach
Virtual Care Expanding From Pandemic Necessity to Delivery System Innovation
Pandemic Innovations That Will Outlast COVID